Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» patents
patents
Samsung Bioepis, J&J Ink Settlement and License Deal for Stelara Biosimilar
Samsung Bioepis, J&J Ink Settlement and License Deal for Stelara Biosimilar
BioSpace
Samsung Bioepsis
JNJ
patents
Stelara
biosimilars
SB17
Flag link:
Teva drops patent case against Lilly after two Ajovy patents deemed invalid
Teva drops patent case against Lilly after two Ajovy patents deemed invalid
Fierce Pharma
Teva Pharmaceutical
legal
Eli Lilly
Ajovy
patents
migraines
Flag link:
AbbVie flexes litigation muscle with Rinvoq patent lawsuit against Sandoz, other generic players
AbbVie flexes litigation muscle with Rinvoq patent lawsuit against Sandoz, other generic players
Fierce Pharma
AbbVie
Rinvoq
patents
legal
Sandoz
Sun Pharma
Intas Pharmaceuticals
Flag link:
European Patent Office declares Moderna mRNA patent invalid
European Patent Office declares Moderna mRNA patent invalid
Reuters
Moderna Therapeutics
MRNA
patents
BioNTech
Pfizer
vaccines
Europe
Flag link:
AbbVie, AstraZeneca, Boehringer and more face FTC's ire for 'improper' patent listings
AbbVie, AstraZeneca, Boehringer and more face FTC's ire for 'improper' patent listings
Fierce Pharma
FTC
Orange Book
patents
AbbVie
AstraZeneca
Boehringer Ingelheim
Flag link:
There's a Silver Lining in Pfizer's Dark Cloud
There's a Silver Lining in Pfizer's Dark Cloud
Motley Fool
Pfizer
earnings
Eliquis
Ibrance
patents
Flag link:
Apple watch imports halted over trade dispute with Masimo
Apple watch imports halted over trade dispute with Masimo
Medical Device Network
Medtech
Apple
Masimo
patents
Apple Watch
Flag link:
At Viatris' request, US agency will review another Novo Nordisk patent on semaglutide
At Viatris' request, US agency will review another Novo Nordisk patent on semaglutide
Fierce Pharma
Viatris
generics
Novo Nordisk
Ozempic
Wegovy
diabetes
patents
USPTO
Flag link:
US Patent Office won't review two Novo Nordisk patents for Wegovy, Ozempic
US Patent Office won't review two Novo Nordisk patents for Wegovy, Ozempic
Yahoo/Reuters
patents
Novo Nordisk
generics
Wegovy
Ozempic
Flag link:
Johnson & Johnson says it won't enforce secondary patents on tuberculosis med Sirturo
Johnson & Johnson says it won't enforce secondary patents on tuberculosis med Sirturo
Fierce Pharma
JNJ
Sirturo
tuberculosis
patents
Flag link:
Supreme Court rebuffs CareDx patent lawsuit over organ-rejection tests
Supreme Court rebuffs CareDx patent lawsuit over organ-rejection tests
Reuters
Caredx
diagnostics
legal
Medtech
patents
Natera
Eurofins Viracor
Supreme Court
Flag link:
CureVac touts 'progress' as German court suspends infringement proceedings against BioNTech
CureVac touts 'progress' as German court suspends infringement proceedings against BioNTech
Fierce Pharma
CureVac
BioNTech
MRNA
patents
legal
Flag link:
US judge overturns Eli Lilly's $176.5 million loss in Teva patent case
US judge overturns Eli Lilly's $176.5 million loss in Teva patent case
Reuters
Eli Lilly
Teva Pharmaceutical
migraines
Ajovy
Emgality
patents
legal
Flag link:
Roche scores—again—in hemophilia drug patent case against Takeda
Roche scores—again—in hemophilia drug patent case against Takeda
Fierce Pharma
Roche
Takeda
patents
legal
Genentech
Baxalta
hemophilia
Flag link:
Why Shares of Bausch Health Companies Fell Tuesday
Why Shares of Bausch Health Companies Fell Tuesday
Motley Fool
Bausch + Lomb
Norwich Pharma Services
patents
Flag link:
FTC, amid biopharma M&A drive, says it will take action against 'sham' patents
FTC, amid biopharma M&A drive, says it will take action against 'sham' patents
Fierce Pharma
FTC
M&A
patents
Flag link:
FTC eyes crackdown on improper drug patents in FDA's Orange Book
FTC eyes crackdown on improper drug patents in FDA's Orange Book
Fierce Pharma
FDA
FTC
Orange Book
patents
Flag link:
Bristol Myers accused of illegal tactics to keep Pomalyst monopoly in lawsuit
Bristol Myers accused of illegal tactics to keep Pomalyst monopoly in lawsuit
Reuters
Bristol Myers Squibb
Celgene
patents
legal
Pomalyst
Flag link:
Alkermes fends off generic versions of Vivitrol until 2027
Alkermes fends off generic versions of Vivitrol until 2027
Clinical Trials Arena
Alkermes
Teva Pharmaceutical
Vivitrol
patents
legal
Flag link:
Axcella granted patent for long COVID fatigue treatment
Axcella granted patent for long COVID fatigue treatment
Medical Marketing and Media
Axcella Therapeutics
COVID-19
Long COVID
AXA1125
patents
Flag link:
Pages
1
2
3
4
5
6
7
8
9
…
next ›
last »